Policy Reform Improves Access to Misoprostol in Ghana
February 29, 2016 | From the field | Population & Reproductive Health
© iStock

The agency responsible for implementing health policies in Ghana has taken steps to improve access to the drug misoprostol that stand to benefit the reproductive health of Ghanaian women. Due in part to MacArthur-supported research by the Columbia University Earth Institute and an evaluation by Public Health Institute, the Ghana Health Service has eased regulations around access to misoprostol and placed it on the essential drug list, ensuring it will be covered by national health insurance programs.

Stay Informed
Sign up for periodic news updates and event invitations. Check out our social media content in one place, or connect with us on Twitter, Facebook, YouTube, and LinkedIn.